Serigne Lo Australasian Melanoma Conference 2026

Abstracts this author is presenting:

• Trial in progress: A randomised phase II trial of concurrent stereotactic body radiotherapy with immunotherapy versus immunotherapy alone in patients with 1-5 extracranial melanoma oligometastases (AXIOM) — Poster Session 2